2004
DOI: 10.1093/nar/gnh167
|View full text |Cite
|
Sign up to set email alerts
|

In vitro selection of Jun-associated proteins using mRNA display

Abstract: Although yeast two-hybrid assay and biochemical methods combined with mass spectrometry have been successfully employed for the analyses of protein-protein interactions in the field of proteomics, these methods encounter various difficulties arising from the usage of living cells, including inability to analyze toxic proteins and restriction of testable interaction conditions. Totally in vitro display technologies such as ribosome display and mRNA display are expected to circumvent these difficulties. In this … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
68
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
4
3
2

Relationship

3
6

Authors

Journals

citations
Cited by 52 publications
(69 citation statements)
references
References 46 publications
0
68
1
Order By: Relevance
“…IVV screening is a powerful tool for identifying biologic macromolecules that participate in protein-protein interactions (15)(16)(17). By using this approach, we identified PKM2 as a mediator of the promotion of the glycolytic phenotype of cancer cells by CD44.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…IVV screening is a powerful tool for identifying biologic macromolecules that participate in protein-protein interactions (15)(16)(17). By using this approach, we identified PKM2 as a mediator of the promotion of the glycolytic phenotype of cancer cells by CD44.…”
Section: Discussionmentioning
confidence: 99%
“…IVV screening and GST pull-down assay IVV selection and glutathione S-transferase (GST) pulldown assay were conducted as described previously (15)(16)(17). The cDNA library for screening was obtained from U251MG cells.…”
Section: Cell Proliferation Assaymentioning
confidence: 99%
“…This result indicates that currently unknown molecular machinery may exist that differs from the translational suppression machinery (Kawahara et al, 2008). Components of this machinery, e.g., binding proteins of Msi1, need to be comprehensively clarified using high-throughput techniques (Rigaut et al, 1999;Horisawa et al, 2004Horisawa et al, , 2008.…”
Section: Resultsmentioning
confidence: 99%
“…These results appear to be in opposition to previous findings that Msi1 represses the translation of its targets (32) and imply the existence of another molecular machinery that activates translation of targets. Components of this machinery, e.g., binding proteins of Msi1, need to be clarified comprehensively by means of high-throughput techniques (77)(78)(79).…”
Section: Waf1mentioning
confidence: 99%